Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA6 | P23280 | 2/20 | 0.32 |
| ▸ | PNMT | P11086 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17467403 | 0.89 | KDM4E (0.37) | KDM4EATML3MBTL1ALDH1A1CA1 | |
| SCHEMBL17467399 | 0.89 | KDM4E (0.37) | KDM4EATML3MBTL1ALDH1A1CA1 | |
| SCHEMBL26531390 | 0.89 | KDM4E (0.41) | KDM4EATML3MBTL1ALDH1A1CA1 | |
| SCHEMBL5028290 | 0.89 | KDM4E (0.37) | KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL17052840 | 0.86 | EDNRB (0.33) | KDM4EATML3MBTL1ALDH1A1EDNRB | |
| SCHEMBL17676393 | 0.86 | KDM4E (0.34) | KDM4EATML3MBTL1ALDH1A1CA1 | |
| SCHEMBL17676370 | 0.86 | KDM4E (0.34) | KDM4EATML3MBTL1ALDH1A1CA1 | |
| SCHEMBL15402268 | 0.85 | PNMT (0.44) | KDM4EATML3MBTL1ALDH1A1CA1 | |
| SCHEMBL12219217 | 0.83 | KDM4E (0.50) | KDM4EATML3MBTL1ALDH1A1DUSP3 | |
| SCHEMBL19849205 | 0.83 | KDM4E (0.36) | KDM4EATML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217823-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-07-06 | — | — | US | disclosed |
| US-20230217823-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217823-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | LEF1, EPB41L2, CTNNBL1 | KDM4E 3122/4885ATM 3445/4885L3MBTL1 1061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.